Lapatinib Induced Suicidal Death of Human Erythrocytes
Lapatinib Induced Suicidal Death of Human Erythrocytes
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: Cell Physiol Biochem Press GmbH & Co KG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: Cell Physiol Biochem Press GmbH & Co KG
Subjects
More information
Scope and Contents
Contents
Background/Aims: The human epidermal growth factor receptors tyrosine kinase inhibitor lapatinib has been shown to trigger suicidal death or apoptosis of tumor cells and is thus used for the treatment of malignancy. Side effects of lapatinib include anemia, which could, at least in theory, result from stimulation of eryptosis, the suicidal death of...
Alternative Titles
Full title
Lapatinib Induced Suicidal Death of Human Erythrocytes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_26624928
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_26624928
Other Identifiers
ISSN
1015-8987
E-ISSN
1421-9778
DOI
10.1159/000438583
